Journal of Maxillofacial and Oral Surgery

, Volume 13, Issue 1, pp 53–58 | Cite as

Nasotracheal Fiberoptic Intubation: Patient Comfort, Intubating Conditions and Hemodynamic Stability During Conscious Sedation with Different Doses of Dexmedetomidine

  • Satish Chandra DhasmanaEmail author
Comparative Study


The study aims to evaluate the efficacy of two doses of dexmedetomidine for sedation during awake fiberoptic intubation (AFOI). The study was designed in a prospective, randomized, double-blinded manner and carried out in an academic medical university. Forty young co-operative patients aged 15–45 years of either sex belonging to ASA class I-II, planned for elective maxillo-facial surgery formed the study group. All patients received midazolam 0.05 mg/kg, glycopyrrolate 0.2 mg, ondansetron 4 mg, and ranitidine 50 mg IV 15 min before as premedication, oxygen by nasal cannula, and topical local anesthetics to the airway. Patients were randomly assigned to one of the groups; dexmedetomedine 1 μg/kg IV (Group L), or dexmedetomidine 1.5 μg/kg IV (Group H). Observer’s Assessment of Alertness/Sedation (OAA/S) was assessed. Primary outcome measurements were: HR, MAP, SpO2 and EtCO2 and secondary outcome measurements were: intubation scores by vocal cord movement, coughing and limb movement, fiberoptic intubation comfort score, nasotracheal intubation score and airway obstruction score. On the first post-operative day, recall, level of discomfort during fiberoptic intubation, adverse events and satisfaction score were also assessed. There were no significant hemodynamic differences between the two groups. OAA/S was significantly better with dexmedetomidine 1.5 μg/kg (p < 0.05) and patients were significantly calmer, more cooperative and satisfied during awake fiberoptic intubation with dexmedetomidine 1.5 μg/kg with fewer transient adverse effects. Dexmedetomidine 1.5 μg/kg proved to be more effective for sedation for awake fiberoptic intubation.


Dexmedetomidine Awake fiberoptic intubation 


  1. 1.
    Randell T, Valli H, Lindgren L (1990) Effects of alfentanil on the responses to awake fiberoptic nasotracheal intubation. Acta Anaesthesiol Scand 34:59–62PubMedCrossRefGoogle Scholar
  2. 2.
    Hartley M, Morris S, Vaughan RS (1994) Teaching fibreoptic intubation. Effect of alfentanil on the haemodynamic response. Anaesthesia 49:335–337PubMedCrossRefGoogle Scholar
  3. 3.
    Bergese SD, Patrick Bender S, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K (2010) A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. J Clin Anaesth 22:35–40CrossRefGoogle Scholar
  4. 4.
    Scher CS, Gitlin MC (2003) Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anesth 50:607–610PubMedCrossRefGoogle Scholar
  5. 5.
    Rai MR, Parry TM, Dombrovskis A, Warner OJ (2008) Remifentanil target-controlled infusion vs propofol target controlled infusion for conscious sedation for awake fibreoptic intubation: a double blinded randomized controlled trial. Br J Anaesth 100:125–130PubMedCrossRefGoogle Scholar
  6. 6.
    Lallo A, Billard V, Bourgain JL (2009) A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 108:852–857PubMedCrossRefGoogle Scholar
  7. 7.
    Knolle E, Ochmke MJ, Gustorff B, Hellwagner K, Kress HG (2003) Target-controlled infusion of propofol for fibreoptic intubation. Eur J Anaesth 20:565–569CrossRefGoogle Scholar
  8. 8.
    Machata AM, Gonano C, Holzer A et al (2003) Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 97:904–908PubMedCrossRefGoogle Scholar
  9. 9.
    Abdelmalak B, Makary L, Hoban J, Doyle DJ (2007) Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 19:370–373PubMedCrossRefGoogle Scholar
  10. 10.
    Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA (2007) Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 19:141–144PubMedCrossRefGoogle Scholar
  11. 11.
    Bergese SD, Candiotti KA, Bokesch PM, Zura A, Wisemandle W, Bekker AY (2010) A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther 17:586–595PubMedCrossRefGoogle Scholar
  12. 12.
    Boyd BC, Sutter SJ (2011) Dexmedetomidine sedation for awakefiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infection. J Oral Maxillofac Surg 69:1608–1612PubMedCrossRefGoogle Scholar
  13. 13.
    Cattano D, Lam NC, Ferrario L, Seitan C, Vahdat K, Wilcox DW, Hagberg CA (2012) Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiol Res Prac 753107:1–7CrossRefGoogle Scholar
  14. 14.
    Kamibayashi T, Maje M (2000) Clinical use of alpha2 adrenergic agonists. Anaesthesia 93:1345–1349CrossRefGoogle Scholar
  15. 15.
    Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ (2000) Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90:699–705PubMedCrossRefGoogle Scholar
  16. 16.
    Venn RM, Hell J, Ground RM (2000) Respiratory effect of dexmedetomidine in the surgical subject requiring intensive care. Crit Care 4:302–308PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Tsai CJ, Chu KS, Lu DV, Wang HM, Lu IC (2010) A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia 65:254–259PubMedCrossRefGoogle Scholar
  18. 18.
    Chu KS, Wang FY, Lu IC, Wang HM, Tsai CJ (2010) The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fiberoptic nasal intubation. Eur J Anesthesiol 27:36–40CrossRefGoogle Scholar
  19. 19.
    Chernik DA, Gillings D, Laine H et al (1990) Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10:244–251PubMedCrossRefGoogle Scholar
  20. 20.
    Puchner W, Egger P, Pühringer F, Löckinger A, Obwegeser J, Gombotz H (2002) Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 46:350–354PubMedCrossRefGoogle Scholar
  21. 21.
    Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G (2004) Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 16:124–126PubMedCrossRefGoogle Scholar
  22. 22.
    Avitsian R, Lin J, Lotto M, Ebrahim Z (2005) Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesthesiol 17:97–99PubMedCrossRefGoogle Scholar
  23. 23.
    Ramsay MA, Lutterman DL (2004) Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 101:787–790PubMedCrossRefGoogle Scholar
  24. 24.
    Venn RM, Bradshaw CJ, Spencer R et al (1999) Preliminary UK experience of dexmedetomidine, a novel agent for post-operative sedation in the intensive care unit. Anaesthesia 54:1136–1142PubMedCrossRefGoogle Scholar
  25. 25.
    Maroof M, Khan RM, Jain D, Ashraf M (2005) Dexmedetomidine is a useful adjunct for awake intubation. Can J Anaesth 52:776–777PubMedCrossRefGoogle Scholar
  26. 26.
    Bhana N, Goa KL, McClellan KJ (2000) Dexmedetomidine. Drugs 59:263–268PubMedCrossRefGoogle Scholar
  27. 27.
    Ebert T, Maze M (2004) Dexmedetomidine: another arrow for the clinician’s quiver. Anesthesiology 101:568–570PubMedCrossRefGoogle Scholar
  28. 28.
    Peden CJ, Cloote AH, Stratford N, Prys-Roberts C (2001) The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of conciousness in patients receiving alfentanil. Anaesthesia 56:408–413PubMedCrossRefGoogle Scholar
  29. 29.
    Jorden VS, Pousman RM, Sanfor MM, Thorborg PA, Hutchens MP (2004) Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 38:803–807PubMedCrossRefGoogle Scholar

Copyright information

© Association of Oral and Maxillofacial Surgeons of India 2013

Authors and Affiliations

  1. 1.Department of AnaesthesiologyKing George’s Medical UniversityLucknowIndia

Personalised recommendations